Get the Stockscreener App
12.07
1.47%
0.175
After Hours:
12.17
0.10
+0.83%
Assertio Holdings Inc stock is traded at $12.07, with a volume of 30,857.
It is up +1.47% in the last 24 hours and up +1.86% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$11.89
Open:
$11.86
24h Volume:
30,857
Relative Volume:
0.67
Market Cap:
$77.45M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
-5.9752
EPS:
-2.02
Net Cash Flow:
$70.07M
1W Performance:
+1.86%
1M Performance:
+1.86%
6M Performance:
-0.34%
1Y Performance:
+4.84%
1-Day Range:
$11.77
$12.35
1-Week Range:
$11.05
$12.35
52-Week Range:
$7.7055
$15.15
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
12.07 | 76.33M | 169.43M | -186.01M | 70.07M | -2.02 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.96 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Assertio Holdings to Release 2025 Financial Results on March 16, 2026 - geneonline.com
Assertio Holdings Inc (ASRT) News, Articles, Events & Latest Updates - Stocktwits
ASRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Assertio (ASRT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2 - PharmiWeb.com
Assertio Holdings (ASRT) grants CFO RSUs and 21,128 stock options - Stock Titan
Assertio (ASRT) President and COO receives new RSUs and stock options grant - Stock Titan
Assertio (ASRT) EVP awarded new RSUs and stock options - Stock Titan
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - marketscreener.com
ASRT Technical Analysis & ETF Price Forecast - Intellectia AI
ASRT Should I Buy - Intellectia AI
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - The Globe and Mail
Assertio (ASRT) EVP logs RSU vesting and 510-share tax withholding - Stock Titan
Assertio Holdings (ASRT) CFO settles RSUs and withholds shares for taxes - Stock Titan
Assertio Holdings (ASRT) COO settles RSUs and withholds shares for taxes - Stock Titan
Assertio (NASDAQ:ASRT) Shares Up 1.7%Still a Buy? - MarketBeat
Profit Review: Is Assertio Holdings Inc likely to announce a buybackInsider Selling & Low Drawdown Investment Strategies - baoquankhu1.vn
Assertio (NASDAQ: ASRT) EVP reports RSU vesting and tax share withholding - Stock Titan
Breakout Zone: Will GSBC benefit from geopolitical trends2025 Risk Factors & Precise Trade Entry Recommendations - baoquankhu1.vn
Are Medical Stocks Lagging Assertio (ASRT) This Year? - Yahoo Finance
Is Assertio Holdings Inc a defensive stockWeekly Trading Summary & Low Drawdown Trading Strategies - baoquankhu1.vn
Does Assertio Holdings Inc. have declining or rising EPSJuly 2025 Spike Watch & Safe Capital Preservation Plans - mfd.ru
Is Assertio Holdings Inc. a strong candidate for buy and holdJuly 2025 Sentiment & Proven Capital Preservation Methods - mfd.ru
Volume Recap: Does Assertio Holdings Inc. outperform in volatile markets2025 Winners & Losers & AI Powered Buy and Sell Recommendations - mfd.ru
US Market Wrap: Can Assertio Holdings Inc maintain sales growthTrade Exit Summary & Safe Capital Preservation Plans - baoquankhu1.vn
Assertio (NASDAQ: ASRT) CFO reports RSU vesting and tax share withholding - Stock Titan
Why Assertio Holdings Inc. stock is rated strong buyGap Down & Long-Term Safe Investment Ideas - mfd.ru
Value Recap: Is Assertio Holdings Inc a strong candidate for buy and hold2025 Pullback Review & Weekly High Potential Stock Alerts - baoquankhu1.vn
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry - simplywall.st
What Could Shift The Assertio Holdings ASRT Narrative After Recent Updates And Peer Signals - Yahoo Finance
Assertio (NASDAQ:ASRT) Stock Price Up 3.9%Here's What Happened - MarketBeat
Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High? - Finviz
There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 28% Share Price Rise - 富途牛牛
Can Assertio Holdings Inc. maintain sales growthWeekly Profit Recap & Capital Protection Trading Alerts - mfd.ru
Pullback Watch: Is Assertio Holdings Inc stock risky to hold now2025 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Pullback Watch: Does Assertio Holdings Inc have declining or rising EPSMarket Growth Review & Daily Volume Surge Signals - baoquankhu1.vn
Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet - sharewise.com
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Assertio regains nasdaq compliance after successful reverse split By Investing.com - Investing.com Nigeria
Assertio regains compliance with Nasdaq minimum bid price requirement By Investing.com - Investing.com India
Short Interest in Assertio Holdings, Inc. (NASDAQ:ASRT) Decreases By 92.8% - MarketBeat
Assertio Therapeutics announces 1-for-15 reverse stock split - MSN
Assertio regains Nasdaq compliance after bid price recovery - MSN
Assertio regains compliance with Nasdaq minimum bid price requirement - Investing.com
Assertio regains nasdaq compliance after successful reverse split - Investing.com
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - The Joplin Globe
Los Angeles Daily NewsAssertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - FinancialContent
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story - Yahoo Finance
Assertio Reports Positive Clinical Trial Results for Rolvedon with Same-Day Dosing - Intellectia AI
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial - The Joplin Globe
Same-day cancer drug shot shows similar results to next-day dosing in trial - Stock Titan
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):